Syquant Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-20,587
Closed -$2M – 22
2019
Q3
$2M Buy
20,587
+1,000
+5% +$100K 0.55% 12
2019
Q2
$2M Sell
19,587
-538,937
-96% -$58.2M 0.64% 10
2019
Q1
$63.6M Buy
+558,524
New +$41.1M 24.61% 1

Syquant Capital's ONCE Position: Q4 2019 in Review

Syquant Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 20,587 shares — an estimated $2M sold.

Syquant Capital first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $63.6M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Syquant Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Syquant Capital sold 20,587 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2M.
  • Syquant Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Syquant Capital's Spark Therapeutics, Inc. Common Stock position peaked at $63.6M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Syquant Capital's 13F filing for Q4 2019, filed 8 Jan 2020.